Lv1
2 积分 2022-05-17 加入
Immunopathogenesis and Therapeutics of Systemic Lupus Erythematosus: an Integrative Review
1天前
待确认
CD19 structure, expression, and signaling: From basic mechanisms to therapeutic targeting
2天前
已完结
New limits proposed for the management of non-mutagenic impurities
25天前
已完结
Deriving acceptable limits for non-mutagenic impurities in medicinal products – Durational adjustments
25天前
已完结
ARI0003: Co-transduced CD19/BCMA dual-targeting CAR-T cells for the treatment of non-Hodgkin lymphoma
2个月前
已完结
ABS0750 FIRST USE OF NOVEL BCMA AND CD19 NANOBODY-BASED COMPOUND CAR-T THERAPY TO TARGET B-CELLS AND PLASMA CELLS IN PRECLINICAL STUDY OF AUTOIMMUNE DISEASES
2个月前
已关闭
An Immunologic Model for Rapid Vaccine Assessment — A Clinical Trial in a Test Tube
2个月前
已完结
Generation of tolerogenic antigen-presenting cells in vivo via the delivery of mRNA encoding PDL1 within lipid nanoparticles
2个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
2个月前
已完结
2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus Erythematosus
3个月前
已完结
皖公网安备34019202002308
